BioCentury | Feb 10, 2021
Finance

Feb. 9 Quick Takes: First-day bump for Adagene; plus Drug Farm, Taysha, Nuance-Antibe, CMS-Luqa and more

...Group. Taysha enters academic gene therapy partnershipsTaysha Gene Therapies Inc. (NASDAQ:TSHA) entered multi-year collaborations with the Cleveland Clinic...
BioCentury | Sep 24, 2020
Finance

Sept. 23 Quick Takes: Zai raises $776M, Silverback $85M; plus Novartis, PureTech, UCB and more

...develop NTRX-07, an orally available cannabinoid receptor agonist in Phase I testing for neuroinflammation. The Cleveland Clinic...
BioCentury | Sep 12, 2020
Politics, Policy & Law

NIH taking action on racial disparities in Alzheimer’s research

...experiences may affect Alzheimer’s risk, and the Cleveland Clinic...
BioCentury | Feb 25, 2020
Distillery Therapeutics

Promoting CX3CL1 expression to treat Alzheimer's

...CONTACT: Riqiang Yan, Cleveland Clinic Foundation, Cleveland, Ohio; University of Connecticut Health, Farmington, Conn. email: riyan@uchc.edu Claire Quang Cleveland Clinic...
BioCentury | Jan 18, 2020
Product Development

Hard, measurable outcomes drive Express Scripts digital formulary

...rescue events per day. Hogg said that through collaborations with other partners, such as the Cleveland Clinic...
BioCentury | Oct 25, 2019
Product Development

Deciding factors in the shifting MS treatment landscape

...more efficacious and equally or better to tolerate,” said Jeffrey Cohen a neurologist at the Cleveland Clinic...
...recent medicines like Ocrevus are more efficacious and equally or better to tolerate.” Jeffrey Cohen, Cleveland Clinic...
BioCentury | Aug 9, 2019
Preclinical News

Aug. 8 Preclinical Quick Takes: Mayo Clinic assay for residual disease; plus camouflage for bacterial agents, Elicio's KRAS vaccine and more

...Heart" ). Anti-CCR5 mAb blocks colorectal cancer growth CytoDyn Inc. (OTCBB:CYDY) said studies conducted at Cleveland Clinic...
...Phosphoinositide 3-kinase catalytic subunit α polypeptide Hongjiang Li and Sandi Wong, Staff Writers leronlimab (PRO 140) NDV-3A, NDV-3 Cleveland Clinic CytoDyn...
BioCentury | Jun 25, 2019
Distillery Therapeutics

Herb-derived flavonoid identified as potential TNBC treatment

...China Normal University, Shanghai, China email: wqlu@bio.ecnu.edu.cn CONTACT: Feixiong Cheng, Cleveland Clinic, Cleveland, Ohio email: chengf@ccf.org Claire Quang Cleveland Clinic East...
BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...cancer High expression of TGFβ pathway genes including TGFBR3 is associated with worse survival outcomes Cleveland Clinic...
BioCentury | May 6, 2019
Distillery Therapeutics

The GJA1 inhibitor clofazimine to treat glioblastoma

...online Apr. 23, 2019 doi:10.1016/j.celrep.2019.03.079 CONTACT: Justin D. Lathia, Cleveland Clinic, Cleveland, Ohio email: lathiaj@ccf.org Claire Quang Clofazimine (LAM320) Cleveland Clinic Gap...
Items per page:
1 - 10 of 351
BioCentury | Feb 10, 2021
Finance

Feb. 9 Quick Takes: First-day bump for Adagene; plus Drug Farm, Taysha, Nuance-Antibe, CMS-Luqa and more

...Group. Taysha enters academic gene therapy partnershipsTaysha Gene Therapies Inc. (NASDAQ:TSHA) entered multi-year collaborations with the Cleveland Clinic...
BioCentury | Sep 24, 2020
Finance

Sept. 23 Quick Takes: Zai raises $776M, Silverback $85M; plus Novartis, PureTech, UCB and more

...develop NTRX-07, an orally available cannabinoid receptor agonist in Phase I testing for neuroinflammation. The Cleveland Clinic...
BioCentury | Sep 12, 2020
Politics, Policy & Law

NIH taking action on racial disparities in Alzheimer’s research

...experiences may affect Alzheimer’s risk, and the Cleveland Clinic...
BioCentury | Feb 25, 2020
Distillery Therapeutics

Promoting CX3CL1 expression to treat Alzheimer's

...CONTACT: Riqiang Yan, Cleveland Clinic Foundation, Cleveland, Ohio; University of Connecticut Health, Farmington, Conn. email: riyan@uchc.edu Claire Quang Cleveland Clinic...
BioCentury | Jan 18, 2020
Product Development

Hard, measurable outcomes drive Express Scripts digital formulary

...rescue events per day. Hogg said that through collaborations with other partners, such as the Cleveland Clinic...
BioCentury | Oct 25, 2019
Product Development

Deciding factors in the shifting MS treatment landscape

...more efficacious and equally or better to tolerate,” said Jeffrey Cohen a neurologist at the Cleveland Clinic...
...recent medicines like Ocrevus are more efficacious and equally or better to tolerate.” Jeffrey Cohen, Cleveland Clinic...
BioCentury | Aug 9, 2019
Preclinical News

Aug. 8 Preclinical Quick Takes: Mayo Clinic assay for residual disease; plus camouflage for bacterial agents, Elicio's KRAS vaccine and more

...Heart" ). Anti-CCR5 mAb blocks colorectal cancer growth CytoDyn Inc. (OTCBB:CYDY) said studies conducted at Cleveland Clinic...
...Phosphoinositide 3-kinase catalytic subunit α polypeptide Hongjiang Li and Sandi Wong, Staff Writers leronlimab (PRO 140) NDV-3A, NDV-3 Cleveland Clinic CytoDyn...
BioCentury | Jun 25, 2019
Distillery Therapeutics

Herb-derived flavonoid identified as potential TNBC treatment

...China Normal University, Shanghai, China email: wqlu@bio.ecnu.edu.cn CONTACT: Feixiong Cheng, Cleveland Clinic, Cleveland, Ohio email: chengf@ccf.org Claire Quang Cleveland Clinic East...
BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...cancer High expression of TGFβ pathway genes including TGFBR3 is associated with worse survival outcomes Cleveland Clinic...
BioCentury | May 6, 2019
Distillery Therapeutics

The GJA1 inhibitor clofazimine to treat glioblastoma

...online Apr. 23, 2019 doi:10.1016/j.celrep.2019.03.079 CONTACT: Justin D. Lathia, Cleveland Clinic, Cleveland, Ohio email: lathiaj@ccf.org Claire Quang Clofazimine (LAM320) Cleveland Clinic Gap...
Items per page:
1 - 10 of 351